Tremblay M - Search Results

1

Serum prostate specific antigen as pre-screening test for prostate cancer.

Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Emond J. Labrie F, et al. Among authors: tremblay m. J Urol. 1992 Mar;147(3 Pt 2):846-51; discussion 851-2. doi: 10.1016/s0022-5347(17)37402-5. J Urol. 1992. PMID: 1371560

2

Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.

Dupont A, Cusan L, Gomez JL, Thibeault MM, Tremblay M, Labrie F. Dupont A, et al. Among authors: tremblay m. J Urol. 1991 Oct;146(4):1064-7; discussion 1067-8. doi: 10.1016/s0022-5347(17)38001-1. J Urol. 1991. PMID: 1716697

3

Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.

Gomez JL, Dupont A, Cusan L, Tremblay M, Suburu R, Lemay M, Labrie F. Gomez JL, et al. Among authors: tremblay m. Am J Med. 1992 May;92(5):465-70. doi: 10.1016/0002-9343(92)90741-s. Am J Med. 1992. PMID: 1349790

4

Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report.

Gomez JL, Dupont A, Cusan L, Tremblay M, Tremblay M, Labrie F. Gomez JL, et al. Among authors: tremblay m. Am J Med. 1992 May;92(5):563-6. doi: 10.1016/0002-9343(92)90756-2. Am J Med. 1992. PMID: 1580304

5

Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancer.

Dupont A, Labrie F, Cusan L, Gomez JL, Tremblay M, Lacourcière Y, Emond J, Monfette G. Dupont A, et al. Among authors: tremblay m. Recent Results Cancer Res. 1992;124:43-54. doi: 10.1007/978-88-470-2186-0_5. Recent Results Cancer Res. 1992. PMID: 1615218 No abstract available.

6

Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women.

Dupont A, Dupont P, Cusan L, Tremblay M, Rioux J, Cloutier D, Mailloux J, De Lignières B, Gutkowska J, Boucher H, et al. Dupont A, et al. Among authors: tremblay m. Maturitas. 1991 Oct;13(4):297-311. doi: 10.1016/0378-5122(91)90238-l. Maturitas. 1991. PMID: 1663571 Clinical Trial.

7

Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women.

Faure N, Labrie F, Olivier G, Tremblay M, Cloutier D, Lemay A, Ferland L, Azadian-Boulanger G, Bouton MM, Husson JM, Raynaud JP. Faure N, et al. Among authors: tremblay m. Maturitas. 1980 Jul;2(2):155-68. doi: 10.1016/0378-5122(80)90050-x. Maturitas. 1980. PMID: 6782429

8

Determination of genotoxicity of the metabolites of the pesticides Guthion, Sencor, Lorox, Reglone, Daconil and Admire by 32P-postlabeling.

Shah RG, Lagueux J, Kapur S, Levallois P, Ayotte P, Tremblay M, Zee J, Poirier GG. Shah RG, et al. Among authors: tremblay m. Mol Cell Biochem. 1997 Apr;169(1-2):177-84. doi: 10.1023/a:1006861621031. Mol Cell Biochem. 1997. PMID: 9089646

9

Generation of monoclonal antibodies reactive with nuclear proteins of human primary breast tumors.

Dinh BL, Tremblay M, Paradis D, Roy PE, Tetu B. Dinh BL, et al. Among authors: tremblay m. Int J Cancer. 1988 Feb 15;41(2):201-5. doi: 10.1002/ijc.2910410207. Int J Cancer. 1988. PMID: 3276634

10

Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene.

Spalinger MR, Sanati G, Chatterjee P, Hai R, Li J, Santos AN, Nordgren TM, Tremblay ML, Eckmann L, Hanson E, Scharl M, Wu X, Boland BS, McCole DF. Spalinger MR, et al. Among authors: tremblay ml. Cell Mol Gastroenterol Hepatol. 2025 Jan 3:101447. doi: 10.1016/j.jcmgh.2024.101447. Online ahead of print. Cell Mol Gastroenterol Hepatol. 2025. PMID: 39756517 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,997 results

Search Page

Filters